Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mouse cDNA microarray analysis uncovers Slug targets in mouse embryonic fibroblasts.

Camino Bermejo-Rodríguez1, María Pérez-Caro, Pedro Antonio Pérez-Mancera

  • 1Laboratorio 13, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Campus Unamuno, 37007 Salamanca, Spain.

Genomics
|November 29, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Titration of RAS alters senescent state and influences tumour initiation.

Nature·2026
Same author

DNA methylation-based classification of hematolymphoid neoplasms.

Blood advances·2026
Same author

Splice-site mutations in POU2AF1 are associated with B-cell lymphomagenesis and therapeutic response.

Scientific reports·2026
Same author

Targeting oncogene-induced senescence in ETV6::RUNX1 pre-leukemic cells.

Cell death discovery·2026
Same author

Deletion of 9p drives B-ALL through heterozygous inactivation of Pax5 and Cd72 in preleukemic cells.

JCI insight·2026
Same author

PD-1 Expression Promotes Immune Evasion in B-ALL.

Hematology reports·2025

Slug (Snai2) maintains the mesenchymal phenotype by regulating key genes involved in self-renewal, epithelial-mesenchymal transition, and survival. These findings offer potential therapeutic targets for Slug-associated cancers.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Cancer Biology

Background:

  • The mesenchymal phenotype is crucial for normal development and cancer progression.
  • Slug (Snai2) is a transcription factor implicated in maintaining the mesenchymal state.
  • Understanding Slug's regulatory mechanisms is essential for therapeutic advancements.

Purpose of the Study:

  • To identify novel target genes regulated by Slug in mesenchymal cells.
  • To elucidate the role of Slug in maintaining the mesenchymal phenotype.
  • To explore potential therapeutic biomarkers in Slug-driven cancers.

Main Methods:

  • Utilized a mouse cDNA microarray (Mousechip-CNIO) with 15,000 clones for expression analysis.
  • Performed gene expression profiling in wild-type and Slug-deficient mouse embryonic fibroblasts (MEFs).

Related Experiment Videos

  • Validated candidate Slug target genes using real-time PCR and Western blot analyses.

    • Main Results:

    • Identified 15 novel Slug target genes, including self-renewal (Bmi1, Nanog), epithelial-mesenchymal transition (Ctnb1, Muc1), survival (Bcl2), and cell cycle/damage (Cdkn1a, Mdm2) genes.
    • Demonstrated that Slug directly regulates these identified genes, as Slug-complementation studies restored aberrant gene expression in Slug-deficient cells.
    • Observed distinct expression patterns of these genes in wild-type versus Slug-deficient MEFs.

    Conclusions:

    • Slug directly regulates a network of genes critical for maintaining the mesenchymal phenotype.
    • These Slug-target genes are implicated in cellular self-renewal, plasticity, and survival.
    • The identified genes represent potential biomarkers for Slug-associated cancers and therapeutic targets.